Búsqueda

Tired of Solvency II? : what boards need to do next

Recurso electrónico / electronic resource
Registro MARC
Tag12Valor
LDR  00000cab a2200000 4500
001  MAP20110058708
003  MAP
005  20111006175252.0
008  111006e20110930esp|||p |0|||b|spa d
040  ‎$a‎MAP‎$b‎spa‎$d‎MAP
084  ‎$a‎7
100  ‎$0‎MAPA20110026561‎$a‎O'Brien, Rory
24500‎$a‎Tired of Solvency II? ‎$b‎: what boards need to do next‎$c‎by Rory O'Brien
520  ‎$a‎You are sick of Solvency II. I wanted to use an alternative word in the title since I know that the mere sight of it will probably encourage you to bin the article before you read it. However, there is no place to hide, and failure to read the article could, in its own right, be a contravention of the Solvency II requirements! There is light at the end of the tunnel, so please read on. In Europe, a huge amount of effort and investment is being focused on Solvency II and, more globally, on enterprise risk management (ERM). Solvency II is a standing agenda item for virtually all insurance company board (boards of directors/supervisory boards) meetings, but many are asking whether the time and effort spent on this is proportionate to the value that is being created. Or is it really a distraction from the difficult job of running the business
650 1‎$0‎MAPA20080564254‎$a‎Solvencia II
650 1‎$0‎MAPA20080591182‎$a‎Gerencia de riesgos
650 1‎$0‎MAPA20080536534‎$a‎ERM
650 1‎$0‎MAPA20080628529‎$a‎Programas de gerencia de riesgos
7102 ‎$0‎MAPA20100009338‎$a‎Towers Watson
7730 ‎$w‎MAP20077000932‎$t‎Emphasis‎$d‎New York : Towers Watson, 1987-‎$g‎30/09/2011 Número 3 - 2011 , p. 32